At The Royal Marsden, world-leading experts are developing new, more effective cancer treatments, saving lives across the UK and beyond. But with one of us diagnosed every 90 seconds*, cancer research breakthroughs are needed more than ever before.
Please give £15 and help make a difference for everyone affected by cancer.
Thanks to an international clinical trial, led by The Royal Marsden, 52% of people diagnosed with advanced melanoma are now surviving the disease for 10 years or more when they receive a combination immunotherapy treatment.
Just 15 years ago, only 1 in 20 patients with advanced melanoma would survive for five years, with many living for just six to nine months.
*Macmillan Cancer Support
Lucy's story
Lucy, 48, was diagnosed with stage 3 melanoma in 2011. She had surgery to remove the cancer and surrounding lymph nodes, but two years later, she received the devastating news that her disease had progressed, and she had just months to live.
Thankfully, Lucy was referred to The Royal Marsden where she joined the international Checkmate 067 trial and received life-saving treatment. The trial involved taking a combination of immunotherapy drugs. Thanks to this trial, in which Professor Larkin and his team at The Royal Marsden played a leading role, these treatments have since been approved and made available on the NHS, offering hope to thousands of melanoma patients.
"My children were five and seven years old when I received the news that I had just months to live, and they are now 17 and 19. I’ve been able to see them go to college, which is amazing."
Lucy is now on a different treatment but says “I wouldn’t be here without the combination immunotherapy treatment I received, it saved my life.”
Your support can help us continue to make life-saving research breakthroughs and develop new and better treatments for cancer patients everywhere, giving people like Lucy more time with their loved ones.
